Erin Cristofaro, MS CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7551 W 22nd Ave, Ferndale, WA 98248 Phone: 412-444-5437 |
Mrs. Angela R Adams, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 7156 Firwood Dr, Ferndale, WA 98248 Phone: 360-380-1228 |
Mrs. Coco Breen, M.A., CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2185 Ferndale Ter, Ferndale, WA 98248 Phone: 360-966-1010 |
Elizabeth Steensland, M.A. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2185 Ferndale Ter, Ferndale, WA 98248 Phone: 360-325-2880 |
News Archive
The U.S. Food and Drug Administration today approved Vabomere for adults with complicated urinary tract infections (cUTI), including a type of kidney infection, pyelonephritis, caused by specific bacteria. Vabomere is a drug containing meropenem, an antibacterial, and vaborbactam, which inhibits certain types of resistance mechanisms used by bacteria.
A questionnaire aimed at assessing how well community oncologists understand "molecular profiling" results from tumor specimens found that 69 percent of participants either said they don't know the answers, or they responded incorrectly.
Thomas A. Moore, chairman and CEO of Advaxis, Inc., the live, attenuated Listeria monocytogenes vaccine company, has issued the following statement to shareholders regarding the recent transition to the OTCQB from the OTCBB:
Some young women simply have more resilience and better coping skills and can shrug off the effect of unwanted cat calls, demeaning looks and sexual advances. Women with low resilience struggle and could develop psychological problems when they internalize such behavior, because they think they are to blame.
Researchers from the Centre for Research in Environmental Epidemiology (CREAL) and the Municipal Institute of Medical Research (IMIM-Hospital del Mar), in collaboration with the Hospital ClĂnic of Barcelona, have participated in an international consortium that has developed a new risk index for COPD patients. With this index, doctors can assess disease severity more objectively and estimate the risk of death.
› Verified 7 days ago